LG Chem acquires approval of diabetes & dyslipidemia complex for first time in Korea

Published: 2017-08-04 16:30:00
Updated: 2017-08-04 13:26:02

LG Chem announced ‘Zemiro,’ a complex drug developed for 5 years as a treatment of diabetes and dyslipidemia, was approved to be commercialized in Korea from the Ministry of Food and Drug Safety. It is the first time for a complex drug of diabetes and dyslipidemia to acquire commercialization app...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.